110 related articles for article (PubMed ID: 9887379)
1. Detailed mapping of the phosphomannomutase 2 (PMM2) gene and mutation detection enable improved analysis for Scandinavian CDG type I families.
Bjursell C; Wahlström J; Berg K; Stibler H; Kristiansson B; Matthijs G; Martinsson T
Eur J Hum Genet; 1998; 6(6):603-11. PubMed ID: 9887379
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of the gene for carbohydrate-deficient glycoprotein syndrome, type I (CDG1): linkage disequilibrium and founder effect in Scandinavian families.
Bjursell C; Stibler H; Wahlström J; Kristiansson B; Skovby F; Strömme P; Blennow G; Martinsson T
Genomics; 1997 Feb; 39(3):247-53. PubMed ID: 9119361
[TBL] [Abstract][Full Text] [Related]
3. PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
Bjursell C; Erlandson A; Nordling M; Nilsson S; Wahlström J; Stibler H; Kristiansson B; Martinsson T
Hum Mutat; 2000 Nov; 16(5):395-400. PubMed ID: 11058896
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis in CDG1 families: beware of heterogeneity.
Matthijs G; Schollen E; Cassiman JJ; Cormier-Daire V; Jaeken J; van Schaftingen E
Eur J Hum Genet; 1998; 6(2):99-104. PubMed ID: 9781052
[TBL] [Abstract][Full Text] [Related]
5. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).
Matthijs G; Schollen E; Pardon E; Veiga-Da-Cunha M; Jaeken J; Cassiman JJ; Van Schaftingen E
Nat Genet; 1997 May; 16(1):88-92. PubMed ID: 9140401
[TBL] [Abstract][Full Text] [Related]
6. Evidence for genetic heterogeneity in the carbohydrate-deficient glycoprotein syndrome type I (CDG1).
Matthijs G; Legius E; Schollen E; Vandenberk P; Jaeken J; Barone R; Fiumara A; Visser G; Lambert M; Cassiman JJ
Genomics; 1996 Aug; 35(3):597-9. PubMed ID: 8812498
[TBL] [Abstract][Full Text] [Related]
7. Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.
Kjaergaard S; Skovby F; Schwartz M
Eur J Hum Genet; 1998; 6(4):331-6. PubMed ID: 9781039
[TBL] [Abstract][Full Text] [Related]
8. An AciI polymorphism in the 3' untranslated region of the human phosphomannomutase 2 (PMM2) gene.
Mizugishi K; Kuwajima K; Obata K; Kondo I
J Hum Genet; 1999; 44(4):266-7. PubMed ID: 10429369
[TBL] [Abstract][Full Text] [Related]
9. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.
Vuillaumier-Barrot S; Barnier A; Cuer M; Durand G; Grandchamp B; Seta N
Hum Mutat; 1999 Dec; 14(6):543-4. PubMed ID: 10571956
[TBL] [Abstract][Full Text] [Related]
12. Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.
Erlandson A; Bjursell C; Stibler H; Kristiansson B; Wahlström J; Martinsson T
Hum Genet; 2001 May; 108(5):359-67. PubMed ID: 11409861
[TBL] [Abstract][Full Text] [Related]
13. Linkage of a locus for carbohydrate-deficient glycoprotein syndrome type I (CDG1) to chromosome 16p, and linkage disequilibrium to microsatellite marker D16S406.
Martinsson T; Bjursell C; Stibler H; Kristiansson B; Skovby F; Jaeken J; Blennow G; Strömme P; Hanefeld F; Wahlström J
Hum Mol Genet; 1994 Nov; 3(11):2037-42. PubMed ID: 7874123
[TBL] [Abstract][Full Text] [Related]
14. PMM2 intronic branch-site mutations in CDG-Ia.
Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
[TBL] [Abstract][Full Text] [Related]
15. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
[TBL] [Abstract][Full Text] [Related]
16. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
[TBL] [Abstract][Full Text] [Related]
17. PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13.
Matthijs G; Schollen E; Pirard M; Budarf ML; Van Schaftingen E; Cassiman JJ
Genomics; 1997 Feb; 40(1):41-7. PubMed ID: 9070917
[TBL] [Abstract][Full Text] [Related]
18. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
[No Abstract] [Full Text] [Related]
19. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
[TBL] [Abstract][Full Text] [Related]
20. Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia).
Matthijs G; Schollen E; Heykants L; Grünewald S
Mol Genet Metab; 1999 Oct; 68(2):220-6. PubMed ID: 10527672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
